Monthly Archives: March 2017

Today's Top Story Study: Oral TXA may be as effective as intravenous TXA for primary THA patients. Findings from a study published in the March 1 issue of The Journal of Bone & Joint Surgery (JBJS) suggest that oral and intravenous formulations of tranexamic acid (TXA) may offer equivalent reductions in blood loss for patients who undergo primary total hip arthroplasty (THA). The authors conducted a randomized, double-blind trial of 83 primary THA patients who received either 1.95 [...]

Today's Top Story President discusses healthcare reform at joint session of Congress. Speaking to a joint session of the U.S. Congress, President Trump offered a broad outline for repeal and replacement of the Affordable Care Act (ACA). As reported by Medscape, key priorities include: Access to healthcare coverage for consumers with pre-existing conditions A stable transition for consumers who have purchased insurance through ACA exchanges Tax credits to purchase coverage along with expanded use of health savings accounts [...]